Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 610M | 516M | 494M | 428M | 380M |
| Gross Profit | 223M | 199M | 180M | 103M | 113M |
| Operating Income | 83M | 74M | 56M | 3M | 25M |
| EBITDA | 84M | 72M | 59M | 12M | 27M |
| Net Income | 71M | 56M | 47M | 8M | 19M |
| EPS (Diluted) | — | — | — | — | — |
Consumer Defensive
Live Price
Offline$78.73
-4.63% today
1Y Change
+134.55%
Window
Jun 26, 2025 → Jun 17, 2026
Coverage: 245 bars · Jun 26, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
The Vita Coco Company, Inc. (COCO) is a Consumer Defensive stock with a market cap of $3.87B and listed on NASDAQ. The stock last traded around $78.73 and up 134.5% across the available one-year price window (Jun 26, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of +18.2%, EPS growth of +26.3%, a dividend yield of 0.0%. What stands out right now is revenue +18.2%, EPS +26.3%, free cash flow -6.9% with operating margin 14.7% and ROIC 20.7%. Valuation already assumes a fairly strong business story at P/E 46.7 and price/sales 5.9. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines COCO price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
COCO
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
COCO Max Drawdown
-23.23%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for COCO and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$379.5M
-11.3% YoY
FY Net Income
$19.0M
+143.3% YoY
Free Cash Flow
-$16.7M
-40.3% YoY
Revenue Growth
+18.2%
EPS Growth
+26.3%
Gross Margin
37.2%
Net Margin
12.6%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 610M | 516M | 494M | 428M | 380M |
| Gross Profit | 223M | 199M | 180M | 103M | 113M |
| Operating Income | 83M | 74M | 56M | 3M | 25M |
| EBITDA | 84M | 72M | 59M | 12M | 27M |
| Net Income | 71M | 56M | 47M | 8M | 19M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 197M | 165M | 133M | 20M | 29M |
| Total Assets | 461M | 362M | 286M | 200M | 197M |
| Total Liabilities | 130M | 104M | 83M | 59M | 74M |
| Shareholder Equity | 332M | 259M | 202M | 141M | 123M |
| Total Debt | 13M | 435K | 1M | 3M | 76K |
| Net Debt | -184M | -164M | -131M | -17M | -29M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
16M
-47.8% YoY
Capital Expenditures
557K
+43.3% YoY
Free Cash Flow
17M
-40.3% YoY
Key ratios
Gross Margin
37.2%
Operating Margin
14.7%
Net Margin
12.6%
ROE
25.4%
Debt / Equity
0.04x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.